Clinical Efficacy of Temocillin Standard Dosing in Patients Treated with Outpatient Antimicrobial Therapy
Evelyne Van den Broucke(KU Leuven), Isabel Spriet(KU Leuven), Lotte Vander Elst(KU Leuven), Otto Van de gaer(KU Leuven), Willy Peetermans(KU Leuven), Matthias Gijsen(KU Leuven), Marnix Mylemans(KU Leuven), Lore Thijs(KU Leuven), Charlotte Quintens(KU Leuven), Stefanie Desmet(KU Leuven)
Cited by 7
Related Papers
Risk factors for community-acquired pneumonia in adults in Europe: a literature review
|Thorax|2013|861
Invasive Aspergillosis in Critically Ill Patients without Malignancy
|American Journal of Respiratory and Critical Care Medicine|2004|544
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data
|The Lancet Digital Health|2021|536
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
|Intensive Care Medicine|2020|464
Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study
|European Heart Journal|2006|400